Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2, and PRN473 reduces venous thrombosis formation in miceChristopher W. Smith(Public Health Ontario), Phillip L.R. Nicolson(National Health Service)Blood AdvancesJuly 5, 202410.1182/bloodadvances.2024012713Cited by 14SaveCiteExport RISWatch citationsRelated PapersReal-world experience with caplacizumab in the management of acute TTP|Blood|2020|157Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI|Haematologica|2018|70